Insta
Single-Dose Of Covaxin On Covid-Recovered People Gives Similar Response As Two Doses On Uninfected: ICMR Study
Bharat Biotech's COVAXIN (Representative Image) (Pic Via BBIL Website)
One of the pilot studies conducted by the Indian Council of Medical Research (ICMR) shows that a single dose of Covaxin on people recovered from Covid-19 is as effective as two doses administered to uninfected individuals.
ICMR has asserted that these are only preliminary findings and that it needs to be corroborated with larger units of data.
Moreover, the authors of the research maintain that taking both doses of the vaccine developed by Bharat Biotech is still recommended.
“This study offers evidence in support of public health-oriented and immunologically sustained vaccine strategies,” the study published by ICMR reads, as reported by the Economic Times.
It added, “If our preliminary findings are confirmed in large population studies, a single dose of BBV152 vaccine may be recommended to previously confirmed SARS-CoV-2 infected individuals so that the naïve individuals could attain the larger benefit of a limited vaccine supply.”
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
